Loading…

Structural and Functional Remodeling of the Left Atrium : Clinical and Therapeutic Implications for Atrial Fibrillation

Left atrial (LA) structural and functional remodeling reflects a spectrum of pathophysiological changes that have occurred in response to specific stressors. These changes include alterations at the levels of ionic channels, cellular energy balance, neurohormonal expression, inflammatory response, a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2008, Vol.51 (1), p.1-11
Main Authors: CASACLANG-VERZOSA, Grace, GERSH, Bernard J, TSANG, Teresa S. M
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 11
container_issue 1
container_start_page 1
container_title Journal of the American College of Cardiology
container_volume 51
creator CASACLANG-VERZOSA, Grace
GERSH, Bernard J
TSANG, Teresa S. M
description Left atrial (LA) structural and functional remodeling reflects a spectrum of pathophysiological changes that have occurred in response to specific stressors. These changes include alterations at the levels of ionic channels, cellular energy balance, neurohormonal expression, inflammatory response, and physiologic adaptations. There is convincing evidence demonstrating an important pathophysiological association between LA remodeling and atrial fibrillation (AF). Measures that will prevent, attenuate, or halt these processes of LA remodeling may have a major public health impact with respect to the epidemic of AF. In this review, we describe the mechanisms involved in LA remodeling and highlight the existing and potential therapeutic options for its reversal, and implications for AF development.
doi_str_mv 10.1016/j.jacc.2007.09.026
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70182317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70182317</sourcerecordid><originalsourceid>FETCH-LOGICAL-h214t-31b0fc1e1f0557c4b3dd888dcd2b593d9e8f40cdff8c80e562e2041c8eb447463</originalsourceid><addsrcrecordid>eNpdkFtr3DAQhUVoaLZp_0AegqC0b3ZnbMuS8haWbhtYCLTps7F1yWrxZaMLIf--arKhkKdhON85MxxCLhBKBGy_7ct9r1RZAfASZAlVe0JWyJgoaib5O7ICXrMCQfIz8iGEPQC0AuV7coYCeQOVXJHH39EnFZPvR9rPmm7SrKJb5rz-MtOizejme7pYGneGbo2N9Dp6lyZ6RddZcurou9sZ3x9Mik7Rm-kwZuFfTKB28c-WzG3c4N04Pgsfyantx2A-Hec5-bP5frf-WWxvf9ysr7fFrsImFjUOYBUatMAYV81Qay2E0EpXA5O1lkbYBpS2VigBhrWVqaBBJczQNLxp63Py9SX34JeHZELsJheUyV_MZkmh44CiqpFn8PMbcL8kn3sIHTJoUbaCY6Yuj1QaJqO7g3dT75-610Iz8OUI9CF3Y30_Kxf-c1IKzPfqv_O8hmY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506196871</pqid></control><display><type>article</type><title>Structural and Functional Remodeling of the Left Atrium : Clinical and Therapeutic Implications for Atrial Fibrillation</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>CASACLANG-VERZOSA, Grace ; GERSH, Bernard J ; TSANG, Teresa S. M</creator><creatorcontrib>CASACLANG-VERZOSA, Grace ; GERSH, Bernard J ; TSANG, Teresa S. M</creatorcontrib><description>Left atrial (LA) structural and functional remodeling reflects a spectrum of pathophysiological changes that have occurred in response to specific stressors. These changes include alterations at the levels of ionic channels, cellular energy balance, neurohormonal expression, inflammatory response, and physiologic adaptations. There is convincing evidence demonstrating an important pathophysiological association between LA remodeling and atrial fibrillation (AF). Measures that will prevent, attenuate, or halt these processes of LA remodeling may have a major public health impact with respect to the epidemic of AF. In this review, we describe the mechanisms involved in LA remodeling and highlight the existing and potential therapeutic options for its reversal, and implications for AF development.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2007.09.026</identifier><identifier>PMID: 18174029</identifier><identifier>CODEN: JACCDI</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Aging ; Angiotensin II Type 1 Receptor Blockers - pharmacology ; Angiotensin II Type 1 Receptor Blockers - therapeutic use ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antifibrinolytic Agents - pharmacology ; Antifibrinolytic Agents - therapeutic use ; Apoptosis ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - therapy ; Biological and medical sciences ; Cardiac arrhythmia ; Cardiac dysrhythmias ; Cardiology ; Cardiology. Vascular system ; Catheter Ablation ; Clinical Trials as Topic ; Confidence intervals ; Drug therapy ; Electric Countershock ; Electrophysiologic Techniques, Cardiac ; Heart ; Heart Atria - drug effects ; Heart Atria - metabolism ; Heart Atria - physiopathology ; Heart attacks ; Heart failure ; Humans ; Hypertension ; Ischemia ; Medical sciences ; Mortality ; Studies</subject><ispartof>Journal of the American College of Cardiology, 2008, Vol.51 (1), p.1-11</ispartof><rights>2008 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jan 1, 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19981231$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18174029$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CASACLANG-VERZOSA, Grace</creatorcontrib><creatorcontrib>GERSH, Bernard J</creatorcontrib><creatorcontrib>TSANG, Teresa S. M</creatorcontrib><title>Structural and Functional Remodeling of the Left Atrium : Clinical and Therapeutic Implications for Atrial Fibrillation</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>Left atrial (LA) structural and functional remodeling reflects a spectrum of pathophysiological changes that have occurred in response to specific stressors. These changes include alterations at the levels of ionic channels, cellular energy balance, neurohormonal expression, inflammatory response, and physiologic adaptations. There is convincing evidence demonstrating an important pathophysiological association between LA remodeling and atrial fibrillation (AF). Measures that will prevent, attenuate, or halt these processes of LA remodeling may have a major public health impact with respect to the epidemic of AF. In this review, we describe the mechanisms involved in LA remodeling and highlight the existing and potential therapeutic options for its reversal, and implications for AF development.</description><subject>Aging</subject><subject>Angiotensin II Type 1 Receptor Blockers - pharmacology</subject><subject>Angiotensin II Type 1 Receptor Blockers - therapeutic use</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antifibrinolytic Agents - pharmacology</subject><subject>Antifibrinolytic Agents - therapeutic use</subject><subject>Apoptosis</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - therapy</subject><subject>Biological and medical sciences</subject><subject>Cardiac arrhythmia</subject><subject>Cardiac dysrhythmias</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Catheter Ablation</subject><subject>Clinical Trials as Topic</subject><subject>Confidence intervals</subject><subject>Drug therapy</subject><subject>Electric Countershock</subject><subject>Electrophysiologic Techniques, Cardiac</subject><subject>Heart</subject><subject>Heart Atria - drug effects</subject><subject>Heart Atria - metabolism</subject><subject>Heart Atria - physiopathology</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Ischemia</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Studies</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpdkFtr3DAQhUVoaLZp_0AegqC0b3ZnbMuS8haWbhtYCLTps7F1yWrxZaMLIf--arKhkKdhON85MxxCLhBKBGy_7ct9r1RZAfASZAlVe0JWyJgoaib5O7ICXrMCQfIz8iGEPQC0AuV7coYCeQOVXJHH39EnFZPvR9rPmm7SrKJb5rz-MtOizejme7pYGneGbo2N9Dp6lyZ6RddZcurou9sZ3x9Mik7Rm-kwZuFfTKB28c-WzG3c4N04Pgsfyantx2A-Hec5-bP5frf-WWxvf9ysr7fFrsImFjUOYBUatMAYV81Qay2E0EpXA5O1lkbYBpS2VigBhrWVqaBBJczQNLxp63Py9SX34JeHZELsJheUyV_MZkmh44CiqpFn8PMbcL8kn3sIHTJoUbaCY6Yuj1QaJqO7g3dT75-610Iz8OUI9CF3Y30_Kxf-c1IKzPfqv_O8hmY</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>CASACLANG-VERZOSA, Grace</creator><creator>GERSH, Bernard J</creator><creator>TSANG, Teresa S. M</creator><general>Elsevier Science</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>2008</creationdate><title>Structural and Functional Remodeling of the Left Atrium : Clinical and Therapeutic Implications for Atrial Fibrillation</title><author>CASACLANG-VERZOSA, Grace ; GERSH, Bernard J ; TSANG, Teresa S. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h214t-31b0fc1e1f0557c4b3dd888dcd2b593d9e8f40cdff8c80e562e2041c8eb447463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Aging</topic><topic>Angiotensin II Type 1 Receptor Blockers - pharmacology</topic><topic>Angiotensin II Type 1 Receptor Blockers - therapeutic use</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antifibrinolytic Agents - pharmacology</topic><topic>Antifibrinolytic Agents - therapeutic use</topic><topic>Apoptosis</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - therapy</topic><topic>Biological and medical sciences</topic><topic>Cardiac arrhythmia</topic><topic>Cardiac dysrhythmias</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Catheter Ablation</topic><topic>Clinical Trials as Topic</topic><topic>Confidence intervals</topic><topic>Drug therapy</topic><topic>Electric Countershock</topic><topic>Electrophysiologic Techniques, Cardiac</topic><topic>Heart</topic><topic>Heart Atria - drug effects</topic><topic>Heart Atria - metabolism</topic><topic>Heart Atria - physiopathology</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Ischemia</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CASACLANG-VERZOSA, Grace</creatorcontrib><creatorcontrib>GERSH, Bernard J</creatorcontrib><creatorcontrib>TSANG, Teresa S. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CASACLANG-VERZOSA, Grace</au><au>GERSH, Bernard J</au><au>TSANG, Teresa S. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural and Functional Remodeling of the Left Atrium : Clinical and Therapeutic Implications for Atrial Fibrillation</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2008</date><risdate>2008</risdate><volume>51</volume><issue>1</issue><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><coden>JACCDI</coden><abstract>Left atrial (LA) structural and functional remodeling reflects a spectrum of pathophysiological changes that have occurred in response to specific stressors. These changes include alterations at the levels of ionic channels, cellular energy balance, neurohormonal expression, inflammatory response, and physiologic adaptations. There is convincing evidence demonstrating an important pathophysiological association between LA remodeling and atrial fibrillation (AF). Measures that will prevent, attenuate, or halt these processes of LA remodeling may have a major public health impact with respect to the epidemic of AF. In this review, we describe the mechanisms involved in LA remodeling and highlight the existing and potential therapeutic options for its reversal, and implications for AF development.</abstract><cop>New York, NY</cop><pub>Elsevier Science</pub><pmid>18174029</pmid><doi>10.1016/j.jacc.2007.09.026</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2008, Vol.51 (1), p.1-11
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_70182317
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Aging
Angiotensin II Type 1 Receptor Blockers - pharmacology
Angiotensin II Type 1 Receptor Blockers - therapeutic use
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Antifibrinolytic Agents - pharmacology
Antifibrinolytic Agents - therapeutic use
Apoptosis
Atrial Fibrillation - physiopathology
Atrial Fibrillation - therapy
Biological and medical sciences
Cardiac arrhythmia
Cardiac dysrhythmias
Cardiology
Cardiology. Vascular system
Catheter Ablation
Clinical Trials as Topic
Confidence intervals
Drug therapy
Electric Countershock
Electrophysiologic Techniques, Cardiac
Heart
Heart Atria - drug effects
Heart Atria - metabolism
Heart Atria - physiopathology
Heart attacks
Heart failure
Humans
Hypertension
Ischemia
Medical sciences
Mortality
Studies
title Structural and Functional Remodeling of the Left Atrium : Clinical and Therapeutic Implications for Atrial Fibrillation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A17%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20and%20Functional%20Remodeling%20of%20the%20Left%20Atrium%20:%20Clinical%20and%20Therapeutic%20Implications%20for%20Atrial%20Fibrillation&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=CASACLANG-VERZOSA,%20Grace&rft.date=2008&rft.volume=51&rft.issue=1&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=0735-1097&rft.eissn=1558-3597&rft.coden=JACCDI&rft_id=info:doi/10.1016/j.jacc.2007.09.026&rft_dat=%3Cproquest_pubme%3E70182317%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h214t-31b0fc1e1f0557c4b3dd888dcd2b593d9e8f40cdff8c80e562e2041c8eb447463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1506196871&rft_id=info:pmid/18174029&rfr_iscdi=true